Valeant Pharmaceuticals International, Inc. – Product Pipeline Review – 2016 Size and Share Published in 2016-08-10 Available for US$ 1500 at Researchmoz.us
Global Markets Directs, Valeant Pharmaceuticals International, Inc. – Product Pipeline Review – 2016, provides an overview of the Valeant Pharmaceuticals International, Inc.s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Valeant Pharmaceuticals International, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Get a Free Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=810386
– The report provides a snapshot of the pipeline therapeutic landscape of Valeant Pharmaceuticals International, Inc.
– The report provides overview of Valeant Pharmaceuticals International, Inc. including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses Valeant Pharmaceuticals International, Inc.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features Valeant Pharmaceuticals International, Inc.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
– Evaluate Valeant Pharmaceuticals International, Inc.s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Valeant Pharmaceuticals International, Inc.
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Valeant Pharmaceuticals International, Inc.s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=810386
Table of Content
Table of Contents 2
List of Tables 6
List of Figures 6
Valeant Pharmaceuticals International, Inc. Snapshot 7
Valeant Pharmaceuticals International, Inc. Overview 7
Key Information 7
Key Facts 7
Valeant Pharmaceuticals International, Inc. – Research and Development Overview 8
Key Therapeutic Areas 8
Valeant Pharmaceuticals International, Inc. – Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products – Monotherapy 12
Pipeline Products – Combination Treatment Modalities 13
Pipeline Products – Partnered Products 14
Partnered Products/Combination Treatment Modalities 15
Pipeline Products – Out-Licensed Products 16
Out-Licensed Products/Combination Treatment Modalities 17
Valeant Pharmaceuticals International, Inc. – Pipeline Products Glance 18
Valeant Pharmaceuticals International, Inc. – Late Stage Pipeline Products 18
Pre-Registration Products/Combination Treatment Modalities 18
Phase III Products/Combination Treatment Modalities 19
Valeant Pharmaceuticals International, Inc. – Clinical Stage Pipeline Products 20
Phase II Products/Combination Treatment Modalities 20
Phase I Products/Combination Treatment Modalities 21
Valeant Pharmaceuticals International, Inc. – Early Stage Pipeline Products 22
Preclinical Products/Combination Treatment Modalities 22
Valeant Pharmaceuticals International, Inc. – Unknown Stage Pipeline Products 23
Unknown Products/Combination Treatment Modalities 23
Valeant Pharmaceuticals International, Inc. – Drug Profiles 24
Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.